Bone: A role for fat precursors in the marrow
Forget your prejudices against adipocytes – fat cells have important roles to play in the body. This is particularly the case in the bone marrow, where bone and blood are constantly renewed throughout life. The bone marrow provides an interface between bones and the blood – blood cells constantly come and go, while bone cells are long-term inhabitants of the marrow space. Bone cells are derived from so-called bone marrow stromal cells (BMSCs), which are usually found near blood vessels. RNA-seq experiments show that a substantial group of BMSCs express genes normally associated with fat cells (Baccin et al., 2020; Baryawno et al., 2019; Tikhonova et al., 2019; Wolock et al., 2019). Moreover, older bones have an increased amount of fat in their marrow, and a large number of BMSCs express the receptor for leptin, a hormone that is often found in fat cells (Zhou et al., 2014). Yet, the roles that fat cells and their precursors play in the bone marrow environment remain largely unknown.
Now, in eLife, Ling Qin from the University of Pennsylvania and co-workers – including Leilei Zhong as first author – report the discovery of a group of cells in the bone marrow that they have named marrow adipogenic lineage precursor (MALP) cells (Zhong et al., 2020).
First, Zhong et al. performed single-cell RNA-seq on BMSCs from young, adult, and aging mice. They fluorescently labeled these cells (Ono et al., 2014) and then used a computational approach to define several distinct stages of mesenchymal progenitors in their paths to becoming bone cells – osteoblasts – and adipocytes. In particular they discovered the MALP cells, which can become fat cells and increase in number as the mice age. These cells express many genes associated with adipocytes, including adiponectin, but do not yet accumulate lipids.
Strikingly, MALP cells form a vast three-dimensional network surrounding blood vessels in the bone marrow known as sinusoidal vessels. MALP cells express a gene called Adipoq, which is also expressed by subcutaneous fat cells. When cells expressing Adipoq were selectively removed from mice, the sinusoidal vessels were severely disrupted. Moreover, loss of these cells caused a massive increase in bone trabeculae (thin rods and plates of bone tissue) throughout marrow space.
However, it has recently been shown that factors called adipokines, including adiponectin and leptin, which are produced by subcutaneous fat cells, negatively regulate bone formation (Zou et al., 2019). This means that the changes observed in the bone marrow when cells expressing Adipoq are removed could simply be due to the disappearance of subcutaneous fat cells. To test whether this was the case, Zhong et al. transplanted subcutaneous fat into mice and then removed the host cells that expressed Adipoq. The mice now had subcutaneous fat cells, but no MALP cells, and still exhibited disrupted sinusoidal vessels and excess trabeculae. This result demonstrates that the changes observed in the bone marrow upon the removal of cells expressing Adipoq are specifically caused by MALP cell removal. These findings suggest that MALP cells are locally important components of the bone marrow environment, particularly in regulating marrow vasculature and bone formation, perhaps by secreting cytokines (Figure 1).
Together with a recent study that demonstrates the importance of pre-adipocyte-like cells in bone regeneration (Matsushita et al., 2020), these findings establish the concept that marrow adipocyte precursors (including MALP cells) play active roles in bone physiology and regeneration. The precise nature of MALP cells still requires further definition. For instance, many types of adipocyte-related cells have been described to date in the bone marrow. Do these cells represent separate or overlapping entities? Do they occupy different locations in bone marrow? If so, does that mean they have different roles? Another important question is whether there is any special feature that determines the identity of marrow adipocytes. How are they different from adipocytes in other areas of the body, and how do they differ metabolically? It is intriguing to think that the adipocyte precursor identity may confer cells with some metabolic advantages to secrete large amounts of cytokines.
References
-
A subset of chondrogenic cells provides early mesenchymal progenitors in growing bonesNature Cell Biology 16:1157–1167.https://doi.org/10.1038/ncb3067
-
Congenital lipodystrophy induces severe osteosclerosisPLOS Genetics 15:e1008244.https://doi.org/10.1371/journal.pgen.1008244
Article and author information
Author details
Publication history
- Version of Record published: May 13, 2020 (version 1)
Copyright
© 2020, Ono
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 1,281
- views
-
- 155
- downloads
-
- 0
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Cell Biology
- Neuroscience
Mutations in Drosophila Swiss cheese (SWS) gene or its vertebrate orthologue neuropathy target esterase (NTE) lead to progressive neuronal degeneration in flies and humans. Despite its enzymatic function as a phospholipase is well established, the molecular mechanism responsible for maintaining nervous system integrity remains unclear. In this study, we found that NTE/SWS is present in surface glia that forms the blood-brain barrier (BBB) and that NTE/SWS is important to maintain its structure and permeability. Importantly, BBB glia-specific expression of Drosophila NTE/SWS or human NTE in the sws mutant background fully rescues surface glial organization and partially restores BBB integrity, suggesting a conserved function of NTE/SWS. Interestingly, sws mutant glia showed abnormal organization of plasma membrane domains and tight junction rafts accompanied by the accumulation of lipid droplets, lysosomes, and multilamellar bodies. Since the observed cellular phenotypes closely resemble the characteristics described in a group of metabolic disorders known as lysosomal storage diseases (LSDs), our data established a novel connection between NTE/SWS and these conditions. We found that mutants with defective BBB exhibit elevated levels of fatty acids, which are precursors of eicosanoids and are involved in the inflammatory response. Also, as a consequence of a permeable BBB, several innate immunity factors are upregulated in an age-dependent manner, while BBB glia-specific expression of NTE/SWS normalizes inflammatory response. Treatment with anti-inflammatory agents prevents the abnormal architecture of the BBB, suggesting that inflammation contributes to the maintenance of a healthy brain barrier. Considering the link between a malfunctioning BBB and various neurodegenerative diseases, gaining a deeper understanding of the molecular mechanisms causing inflammation due to a defective BBB could help to promote the use of anti-inflammatory therapies for age-related neurodegeneration.
-
- Cancer Biology
- Cell Biology
Enhanced protein synthesis is a crucial molecular mechanism that allows cancer cells to survive, proliferate, metastasize, and develop resistance to anti-cancer treatments, and often arises as a consequence of increased signaling flux channeled to mRNA-bearing eukaryotic initiation factor 4F (eIF4F). However, the post-translational regulation of eIF4A1, an ATP-dependent RNA helicase and subunit of the eIF4F complex, is still poorly understood. Here, we demonstrate that IBTK, a substrate-binding adaptor of the Cullin 3-RING ubiquitin ligase (CRL3) complex, interacts with eIF4A1. The non-degradative ubiquitination of eIF4A1 catalyzed by the CRL3IBTK complex promotes cap-dependent translational initiation, nascent protein synthesis, oncogene expression, and cervical tumor cell growth both in vivo and in vitro. Moreover, we show that mTORC1 and S6K1, two key regulators of protein synthesis, directly phosphorylate IBTK to augment eIF4A1 ubiquitination and sustained oncogenic translation. This link between the CRL3IBTK complex and the mTORC1/S6K1 signaling pathway, which is frequently dysregulated in cancer, represents a promising target for anti-cancer therapies.